Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms

C C Blyth; A J Currie; S P Wiertsema; N. Conway; L A S Kirkham; A Fuery; F Mascaro; G C Geelhoed; P C Richmond

doi:10.1016/j.vaccine.2011.05.054

Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms

C C Blyth, A J Currie, S P Wiertsema, N. Conway, L A S Kirkham, A Fuery, F Mascaro, G C Geelhoed, P C Richmond

Research output: Contribution to journal › Article › peer-review

42 Citations (Scopus)

Abstract

Increased numbers of children presenting with febrile adverse events following trivalent influenza vaccine (TIV) were noted in Australia in 2010. We describe the epidemiology and clinical features of the adverse events and explore the biological basis for the adverse events using an in vitro model.

Original language	English
Pages (from-to)	5107-5113
Number of pages	7
Journal	Vaccine
Volume	29
Issue number	32
DOIs	https://doi.org/10.1016/j.vaccine.2011.05.054
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2011.05.054

Cite this

@article{3b8376f065bf4b1f8cde375b5bdfc0ca,

title = "Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms",

abstract = "Increased numbers of children presenting with febrile adverse events following trivalent influenza vaccine (TIV) were noted in Australia in 2010. We describe the epidemiology and clinical features of the adverse events and explore the biological basis for the adverse events using an in vitro model.",

author = "Blyth, {C C} and Currie, {A J} and Wiertsema, {S P} and N. Conway and Kirkham, {L A S} and A Fuery and F Mascaro and Geelhoed, {G C} and Richmond, {P C}",

year = "2011",

doi = "10.1016/j.vaccine.2011.05.054",

language = "English",

volume = "29",

pages = "5107--5113",

journal = "Vaccine",

issn = "1873-2518",

publisher = "Elsevier BV",

number = "32",

}

TY - JOUR

T1 - Trivalent influenza vaccine and febrile adverse events in Australia, 2010

T2 - clinical features and potential mechanisms

AU - Blyth, C C

AU - Currie, A J

AU - Wiertsema, S P

AU - Conway, N.

AU - Kirkham, L A S

AU - Fuery, A

AU - Mascaro, F

AU - Geelhoed, G C

AU - Richmond, P C

PY - 2011

Y1 - 2011

N2 - Increased numbers of children presenting with febrile adverse events following trivalent influenza vaccine (TIV) were noted in Australia in 2010. We describe the epidemiology and clinical features of the adverse events and explore the biological basis for the adverse events using an in vitro model.

AB - Increased numbers of children presenting with febrile adverse events following trivalent influenza vaccine (TIV) were noted in Australia in 2010. We describe the epidemiology and clinical features of the adverse events and explore the biological basis for the adverse events using an in vitro model.

U2 - 10.1016/j.vaccine.2011.05.054

DO - 10.1016/j.vaccine.2011.05.054

M3 - Article

C2 - 21640152

VL - 29

SP - 5107

EP - 5113

JO - Vaccine

JF - Vaccine

SN - 1873-2518

IS - 32

ER -

Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this